The first stop for professional medicines advice

Verapamil

Published
Topics: Cardiovascular system disordersPatent expiriesSafety in Breastfeeding · Stability in dosette boxesVerapamil ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Half Securon SR · Mylan
    2. Vertab SR · Dexcel Pharma Ltd
    3. Verapress MR · Dexcel Pharma Ltd
    4. Securon SR · Mylan
  4. Lactation Safety Information

dm+d

47898004

Articles

Using calcium-channel blockers during breastfeeding

2 June 2023Nifedipine and verapamil are the CCBs of choice. Recommendations apply to full term and health infant only.

Managing peripheral oedema caused by calcium channel blockers

26 September 2022All calcium channel blockers may cause peripheral oedema. There are different treatment options and the incidence can be affected by different factors.

What injections can be given orally or via enteral feeding tubes?

6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
Search Articles

Medicine Compliance Aid Stability

Half Securon SRMylan

Mylan
Half Securon SR
Tablets m/r 120mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
31 October 2022
Usage of Medicines in Compliance Aids

Vertab SRDexcel Pharma Ltd

Dexcel Pharma Ltd
Vertab SR
Tablets m/r 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
31 October 2022
Usage of Medicines in Compliance Aids

Verapress MRDexcel Pharma Ltd

Dexcel Pharma Ltd
Verapress MR
Tablets m/r 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
31 October 2022
Usage of Medicines in Compliance Aids

Securon SRMylan

Mylan
Securon SR
Tablets m/r 240mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
31 October 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Yes
-
Limited published evidence of safety
Doses up to 360mg daily produce small amounts in breast milk which would not be expected to cause adverse effects in the breastfed infant
Safety in Lactation: Drugs for hypertension
3 August 2020
Bibliography